Valois has made two major instrument investments that will allow it
to dramatically increase productivity as it dons the diving suit to
undertake environmental testing in its cleanrooms.
A new improved range of urethane-based floor systems that is
claimed to help pharma manufacturers reduce the level of bacteria
contamination in their production environment has been launched.
Isogenica has entered into a research and licence option agreement
with UCB for the discovery of novel peptide ligands, which UCB
intends to incorporate into therapeutic products.
Researchers think they have found an explanation as to why
"flesh-eating" bacteria are so resistant to antibiotic treatment,
which could contribute to new strategies for treating necrotizing
fasciitis, halting its rapid...
Researchers think that they have developed an effective tactic,
which aims to stop the spread of bacterial infections that have
become resistant to antibiotic treatment paving the way for future
therapies.
Researchers believe that the discovery of enzymes that play a key
role in building membranes of disease-causing bacteria has ended a
25-year mystery and paves the way for new drug development against
certain types of bacteria.
Scientists believe they have discovered a novel way in treating
people suffering from anthrax poisoning, which could overcome the
problem of antibiotic resistance that is becoming increasingly
common in southern and Eastern Europe...
Researchers have identified a protein that is thought to defend the
intestinal against microbial invaders offering new insights into
how the intestine fends off pathogens and potentially leading to
new inflammatory bowel disease medications.
AM Pharma has been awarded a US and EU patent for its antimicrobial
peptide to be used in the development of a novel class of drugs
with high efficacy against a broad spectrum of bacterial, fungal
and viral infections.
A new white paper has been made available to laboratories
worldwide, which aims to minimise the risk of infection through
focused biosafety reviews and further reinforce the required level
of infection control.
A recently published report has highlighted the use of antibiotics
in the rearing of fish could promote bacterial resistance leading
to the evolution of resistant strains of bacteria in humans as well
as the fish themselves.
Biotechnology firm Invitrogen has opened a new facility in New York
which can make its Advanced Granulation Technology (AGT) media
totally free of animal origin components while addressing key
bottlenecks in drug production.
Researchers, who believe they have discovered only the third
entirely new antibiotic developed in the last four decades, have
developed an antibiotic, which targets microorganisms that include
MRSA.
Biopharmaceuticals manufacturer Cobra will provide process
development and manufacturing of two HIV vaccine candidates for
evaluation in clinical trials under an agreement with the
International AIDS Vaccine Initiative (IAVI) and...
US-based Nabi Biopharmaceuticals has secured an exclusive supply
and contract manufacturing deal with French-based vaccines giant
Sanofi Pasteur to streamline the production of its rabies vaccine.
BioTools Swiss has made available its new media preperator for the
laboratory automation industry, which claims to be the fastest
processor of readily dispensable agar/nutrient medium.
A leading scientist believes that cosmetic considerations and a
lack of patent opportunities is stopping the pharmaceutical
industry from investing in the development of a new therapy proven
to be effective in the treatment of MRSA.
A new laboratory method for distinguishing pathogens from harmless
relatives has been developed by scientists in the US. The
high-throughput technique will enable the quick identification of
pathogens, which could be used for bioterror...
A consortium of researchers has detailed the activity of a novel
drug compound that kills multiple HIV strains via a unique
mechanism of action. The discovery brings with it hope in using
this compound in both topical and systemic...
Scientists have re-engineered a well-known antibiotic to counter
drug resistance forming a new molecule in the process that could
assist in treating hospital infections, which were previously
resistant to common antibiotics putting...
Researchers have come up with definitive proof that proteins can be
custom-designed for a new and pre-determined activity, signalling a
new direction in drug production as well as having relevance to the
biotechnological and medicinal...
Enanta Pharmaceuticals has announced the initiation of Phase 2
studies investigating a first in class antibiotic candidate that
treats community-acquired respiratory tract infections, which has
become the sixth most common cause of...
Filtration specialists, Pall, and Biotrace have signed an agreement
to market microbiological air monitoring technology to the
pharmaceutical industry. The deal focuses on microbiological
monitoring of manufacturing processes, which...
The threat of antibiotic resistance reared its ugly head again
after US researchers found that the most common antibiotic
treatments do not work in a significant number of cases, leading
for calls to find viable alternatives to ageing,...
Scientists have described the cellular structure of a protein that
plays a critical role in drug resistance, which may open up new
avenues for laboratory research that may result in the enhancement
of existing therapies for Cancer...
Grunenthal has developed a novel method of delivering drugs to
children in the form of a drinking straw, which is set to provide a
solution to administering treatment to patients who cannot tolerate
unpleasant tasting drugs.
Laboratory researchers believe that a recent discovery will prove
highly effective in stopping the progress of anthrax infection,
further developing reliable treatments to diagnose this killer
microorganism.
A new antibiotic that not only acts as a traditional antibiotic but
also acts on bacterial infections that have developed resistance to
existing types of antibiotic could herald the emergence of a new
tool to fight infections.
STMicroelectronics and Mobidiag unveil a new technology that
enables rapid bacterial diagnosis. The new lab-on-a-chip
application allows a more accurate detection of infectious diseases
that will lead to better treatment choices.
US biotechnology firm XOMA has granted Wyeth a non-exclusive,
worldwide license for a technology used to make biologic drugs such
as antibodies in bacteria instead of mammalian cells.
Researchers in the US have identified a molecular version of an
anchor, which allows the access of bacteria into the central
nervous system. By blocking the molecules anchoring ability, its
potential importance as a drug target may...
A small interfering RNA (siRNA) library developed by Ambion has
been used to provide a detailed analysis of endocytosis, the
process by which cells internalise nutrient, cell signalling, and
other molecules.
An ionic silver complex designed for human antimicrobial use has
received a US patent, in a move that could well see increased usage
of this technology that exhibits broad-spectrum antimicrobial
qualities as well as displaying a lack...
A US company has revealed a unique method in drug development that
uses transgenic tobacco plants to cultivate the human protein
CaroRx, which could prevent tooth decay in the future.
Researchers have discovered the structural basis for antibiotic
resistance to common pathogenic bacteria, which could herald the
design and development of a new class of antibiotic drugs.
Culture media supplier Oxoid has expanded the use of innovative
chromogenicsubstrates within its chromogenic media range to provide
clearly visibleanswers on a single culture plate.
Pall has launched a new gas filter that should increase safety in
the production of biologic drugs that need to be made in an
oxygen-enriched environment, writes Phil Taylor.
Researchers have developed miniature sensors that reduce time taken
for DNA analysis. The sensors have the same size and thickness as a
fingernail and will have uses in testing genetic toxicity in new
drugs and identifying bacterial...
The world's largest drug company, Pfizer, is to make use of a gene
expression system developed at Dowpharma for the production of one
of its therapeutic proteins.
In the US, Wave Biotech and ILC Dover have launched a new version
of their disposable mixing device for use in the pharmaceutical,
biotechnology and other industries.
UK-based biotechnology firm Biotica Technology and the University
of Cambridge have secured funding for a collaborative research
initiative into new expression systems for the production of
polyketides.
Sigma-Aldrich introduces the TargeTron gene knockout system, a tool
that is set to feature prominently in functional genomics and
systems biology. It incorporates technology that exploits the
retrohoming ability of group II introns,...
Researchers have identified a promising new drug target in their
fight against resilient Staphylococcus bacteria that can be
transmitted to patients in hospitals via contaminated medical
implants.
US peptide developers Helix BioMedix has entered into collaboration
with Smith & Nephew, which aims to focus on the development of
HB50, the company's lead topical anti-infective peptide.
Wyeth Pharmaceuticals has announced the submission of a global
registration dossier for its investigational antibiotic Tygacil
(tigecycline), a new class of treatment for intra-abdominal and
skin infections.
Scientists have found a molecular weakness in the organism that
causes pneumonia, providing a target for the development of a new
class of antibiotics that could eventually eradicate the disease.